Most Active Stocks

COCHINSHIP
JUBLINGREA
BSE
SCI
INDIGO
GRSE
BEL
RELIANCE
HAL
HDFCBANK
INFY
ICICIBANK
RPOWER
CDSL
MAZDOCK
ONGC
BAJFINANCE
KOTAKBANK
OIL
SBIN

Kopran Limited

Drug Manufacturers - General | Healthcare

Company Overview

Kopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.

Key Information

Market Cap

9584691200

Current Price

198.5

52 Week Range

155.0 - 369.7

Previous Close

196.41

Open

197.15

Industry

Drug Manufacturers - General

Sector

Healthcare

Contact Details

Address

Parijat House, 1076, Dr. E. Moses Road Worli, Mumbai, 400018, India

Phone

+91-22436-61111

Fax

+91-22249-50363

Website

https://www.kopran.com

Financials

Day Low

196.4

Day High

200.75

Dividend Yield

1.55

PE Ratio

24.536465

Earnings Per Share

8.09

Beta

0.561

EBITDA

728998976

Book Value

107.662

EPS

Company Officers

Name Title Age Year Born
Mr. Surendra Shrikrishna Somani B.Com. Executive Vice Chairman & MD 70 1954
Mr. Basant Kumar Soni Chief Financial Officer - -
Mr. Sunil Sodhani Company Secretary & Compliance Officer - -
Mr. Ajit Jain FCA Chief Operating Officer 63 1961
Ms. Vandana Somani Director - -

Company Details

Stock History

Explore More Stocks